Tag Archives: NIAID

NIH names new Office of AIDS Research director

By on .

Post has been open since June 2015 departure of longtime leader Dr. Jack Whitescarver “We still need a vaccine and we need a cure. So we need ways to protect people not infected, and we need to try to find ways that we can cure people who are . . .” Dr. Maureen Goodenow, in […]

START findings highlight treatment divide

By on .

“It’s just more scientific evidence to back what we’ve been saying for a long time.” Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases, announcing the conclusion of the START trial, which began in 2011 to assess “the best time for healthy HIV-infected people to begin antiretrovirals.” The announcement from the National Institute […]

AIDS 2014: HIV and tuberculosis are one disease in Southern Africa

By on .

Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia through the coming week, with updates on research, policy and insights from the 20th International AIDS Conference. MELBOURNE, AUSTRALIA – “We must ensure that the worlds of HIV and TB focus on individual human beings instead of individual diseases” This message headlined remarks from Mark […]

AIDS vaccine update: With Thai trial, broadly neutralizing antibodies, new technologies and monkeys that met the SIV challenge, “we’re closer than ever”

By on .

NIH AIDS Vaccine Research Program Director: “The future of HIV-1 Vaccines is bright.” In 1997, scientists announced the birth of Dolly the cloned sheep, a computer named Deep Blue beat reigning chess champion Gary Kasparov, and the Hubble telescope brought the far reaches of outer space closer. President Bill Clinton pointed to all of these […]

Fauci: HIV imaging yields “significant advance” in vaccine inquiry

By on .

For 15 years scientists have worked to get a clear enough picture of how the protein surrounding the virus that leads to AIDS interacts with antibodies, to guide the development of a vaccine that would instigate an effective immune response. For years, the delicate and complicated structure of that protein has made that difficult, and […]

Study yields clues on HIV strains with “evolutionary advantage” that can guide vaccine development

By on .

While the virus that leads to AIDS has long been recognized to be “sloppy” in its replication, changing over time into divergent strains,  a National Institutes of Health-funded study recently found the virus that a person transmits tends to continue to look like the virus that originally infected that person. The study, significant for the […]

Sustainable HIV prevention possibilities present choices, challenges

By on .

When he looks at what biomedical science can do in the next decade to prevent HIV transmission, Jim Turpin of the National Institutes of Health said, he thinks of the lyrics of a Timbuk3 song: “The future’s so bright I gotta wear shades.” By, which, actually, he means — don’t get blinded by the light; […]

Dr. Fauci on innovative HIV vaccine initiative awards: “There are fundamental questions that remain unanswered”

By on .

Researchers at 14 institutions will explore new approaches to designing a vaccine against HIV with awards that are part of an anticipated four-year, $34.8 million initiative, the National Institute of Allergy and Infectious Diseases announced today. The awards reflect directions suggested by previous research, as well as the need to explore new avenues toward a […]

Enhanced NIH Funding Vital For Success in Battle Against AIDS

By on .

If there’s any question about the value of U.S. investments in scientific research on HIV/AIDS, Anthony Fauci probably put it to rest today by noting that in the period since HIV first emerged, “we went from a 26-week lifespan to a 40-year-plus life span” for those infected with the virus. Talk about measureable outcomes. That […]

NIAID’s Fauci on Tuberculosis: “We have much catching up to do”

By on .

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, delivered a forceful message on the need for a “storm” of attention and resources devoted to developing new TB treatment and prevention efforts. “It is imperative that we transform the way we diagnose, treat, prevent, and control TB — through biomedical research and […]